Durham's Aerie Pharma raises $316.5M, to use funds for eye disease drug development | WRAL TechWire
Aerie Pharmaceuticals Launches GMP Facility - Contract Pharma
Aerie Pharmaceuticals – Capital Sign Solutions
Aerie
Aerie Pharmaceuticals Inc (AERI) Q3 2020 Earnings Call Transcript
Should Aerie Pharmaceuticals Inc (AERI) be in Your Portfolio? - InvestorsObserver
Aerie Pharma to use DSM polymers to develop eye drug delivery tech
Eye disease drug firm Aerie Pharma acquires Spanish company for $10M | WRAL TechWire
Aerie Pharmaceuticals and Ramot at Tel Aviv University Enter Research Collaboration | Business Wire
Aerie-Pharma -
Aerie Pharma appoints Richard Rubino as CFO | Procurement & Supply Chain | Healthcare Global
Aerie Pharmaceuticals (AERI) Investor Presentation - Slideshow (NASDAQ:AERI) | Seeking Alpha
Aerie-Pharma-Newsletter | OIS
Aerie Pharmaceuticals - Crunchbase Company Profile & Funding
Rise in the sentiment of investors in Aerie Pharmaceuticals INC. – Medgazette 24
Aerie Pharmaceuticals | Leading Ophthalmic Pharmaceuticals
Aerie Pharma on go with mid-stage study of eye drop for dry eye (NASDAQ:AERI) | Seeking Alpha
Aerie-Pharma -
Aerie Pharmaceuticals Inc - AnnualReports.com
Aerie Pharma: Finding Value In The Ophthalmic Space (NASDAQ:AERI) | Seeking Alpha
AERIE PHARMACEUTICALS, INC. : AERI Stock Price | MarketScreener
Compliance Program | Aerie Pharmaceuticals, Inc.
Aerie in Europe - EuroTimes
